Informe nº Osteba D12-04. - Euskadi.net

4.8.5. bibliografia1. American Psychiatric Association (APA). TaskForce on Electroconvulsive Therapy. APA, 2001.2. American Psychiatric Association (APA). Guidanceon Schizophrenia. APA, 2006.3. Braga RJ, Petrides G. The combined use ofelectroconvulsive therapy and antipsychoticsin patients with schizophrenia. J ECT. 2005Jun; 21(2):75-83.4. Braga RJ, Petrides G. Somatic therapies fortreatment-resistant psychiatric disorders. RevBras Psiquiatria. 2007; 29 (Supl II): S77-84.5. Chanpattana W y cols. Short-term effect ofcombined ECT and neuroleptic therapy intreatment-resistant schizophrenia. J ECT.1999; 15(2): 129-39.6. Chanpattana W y cols. Continuation ECT intreatment-resistant schizophrenia: a controlledstudy. J ECT. 1999 Sep; 15(3): 18-92.7. Chanpattana W y cols. Acute and maintenanceECT with flupentixol in refractory schizophrenia:sustained improvements inpsychopathology, quality of life and socialoutcomes. Schizophr Res. 2003; 63: 189-193.8. Chanpattana W y cols. Seizure treshold riseTuring electroconvulsive therapy in schizophrenicpatients. Psychiatry Res. 2000; 96: 31-40.9. Chanpattana W y cols. Combined ECT andneuroleptic therapy in treatment-refractoryschizophrenia: prediction of outcome.Psychiatry Res. 2001; 105: 107-115.10. Emmanuel MD y cols. Somatic augmentationstrategies in clozapine-resistance-what Facts?Clin Neuropharmacology. 2006 Jan/Feb; 29(1): 34-44.11. Havaki-Kontaxaki MD y cols. Concurrent administrationof clozapine and electroconvulsivetherapy in clozapine-resistantschizophrenia. Cli Neuropharmacol. 2006Jan/Feb; 29 (1).12. Helio Elkis MD, Phd. Treatment-Resistant Schizophrenia,Brazil, 2007. Psychatr Clin N Am.2007; 30: 511-533.13. Kazumasa Suzuki MD y cols. Continuationelectroconvulsive therapy for relapse preventionin middle-aged and elderly patients withintractable catatónico schizophrenia.Psychiatry Clin Neurosci. 2005; 59: 481-489.14. Kazumasa Suzuki MD y cols. Adjusting thefrequency of continuation and maintenanceelectroconvulsive therapy to prevent relapseof catatónico schizophrenia in middle-agedand elderly patients who are relapse-prone.Psychiatry Clin Neurosci. 2006; 60: 486-492.15. Keuneman R, Weerasundera R, Castle D. Therole of ECT in schizophrenia. AustralianPsychiatry. 2002 Dec; 10(4).16. Kho KH y cols. Electroconvulsive therapy forthe treatment of clozapine nonresponderssuffering from schizophrenia. Eur Arch ClinNeurosci. 2004; 254: 372-379.17. McGorry P, Killackey E, Elkins K, Lambert M,Lambert T. Guías de la práctica clínica para eltratamiento de la esquizofrenia del Real Colegiode Psiquiatras Australiano y Neozelandés.http://psicondec.rediris.es. Australia, 2003.18. National Institute for Clinical Excellence(NICE): Guidance on the use of electroconvulsivetherapy. London: NICE, 2003.19. Rami L y cols. Absence of additional cognitiveimpairment in schizophrenia patients Turingmaintenance electroconvulsive therapy. SchizophrBull. 2004; 30(1).20. Tharyan P, Adams CE. Terapia electroconvulsivapara la esquizofrenia (Revisión Cochranetraducida). Biblioteca Cochrane Plus, número3, 2008. Oxford.21. Wai-Kwong T y cols. Efficacy of electroconvulsivetherapy in treatment-resistant schizophrenia:a prospective open trial. ProgNeuropsychopharmacol Biol Psychiatry. 2003May; 27(3): 373-39.22. Williams L y cols. Clozapine-resistant schizophrenia:a positive approach. British JPsychiatry. 2002; 181: 184-187.esTRaTegIas123